N/A
Manufactured by Lil' Drug Store Products, Inc.
4,540 FDA adverse event reports analyzed
Last updated: 2026-04-14
BUFFERED ASPIRIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Lil' Drug Store Products, Inc.. The most commonly reported adverse reactions for BUFFERED ASPIRIN include CHRONIC KIDNEY DISEASE, ACUTE KIDNEY INJURY, RENAL FAILURE, END STAGE RENAL DISEASE, RENAL INJURY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BUFFERED ASPIRIN.
Out of 1,394 classified reports for BUFFERED ASPIRIN:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 4,540 FDA FAERS reports that mention BUFFERED ASPIRIN. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include CHRONIC KIDNEY DISEASE, ACUTE KIDNEY INJURY, RENAL FAILURE, END STAGE RENAL DISEASE, RENAL INJURY, GASTROOESOPHAGEAL REFLUX DISEASE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Lil' Drug Store Products, Inc. in connection with BUFFERED ASPIRIN. Always verify the specific product and NDC with your pharmacist.